Arcturus Therapeutics Ltd
(ARCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,571 | -10,902 | -5,622 | -2,445 | -3,520 |
| Depreciation Amortization | 111 | 410 | 301 | 199 | 49 |
| Accounts receivable | -697 | 3,153 | 2,626 | 1,887 | N/A |
| Accounts payable and accrued liabilities | 852 | -1,537 | -1,482 | -1,149 | -40 |
| Other Working Capital | 6,073 | 7,364 | -2,140 | -1,526 | -2,012 |
| Other Operating Activity | -129 | 1,052 | 856 | -697 | 559 |
| Operating Cash Flow | $-361 | $-460 | $-5,461 | $-3,731 | $-4,964 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11,587 | 10,577 | N/A | N/A | 7,335 |
| PPE Investments | -362 | -222 | -100 | -16 | -1 |
| Investing Cash Flow | $11,225 | $10,355 | $-100 | $-16 | $7,334 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,650 | 5,650 | N/A | N/A |
| Common Stock Issued | 294 | 1,348 | 292 | 5,489 | N/A |
| Financing Cash Flow | $294 | $6,998 | $5,942 | $5,489 | $N/A |
| Beginning Cash Position | 25,238 | 8,345 | 8,345 | 8,345 | 2,304 |
| End Cash Position | 36,396 | 25,238 | 8,726 | 10,087 | 4,674 |
| Net Cash Flow | $11,158 | $16,893 | $381 | $1,742 | $2,370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -361 | -460 | -5,461 | -3,731 | -4,964 |
| Capital Expenditure | -362 | -251 | -100 | -16 | -1 |
| Free Cash Flow | -723 | -711 | -5,561 | -3,747 | -4,965 |